Investigation Overview
July 03, 2017 (Shareholders Foundation) - An investigation on behalf of investors in shares of RXi Pharmaceuticals Corp (NASDAQ:RXII) was announced over potential breaches of fiduciary duties by certain officers and directors at RXi Pharmaceuticals. The investigation by a law firm concerns whether certain RXi Pharmaceuticals officers and directors breached their fiduciary duties and ...
You must register (for free) or login to view the entire investigation.